Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/31/2012CN102125570B Use of chikusetsusaponin v and/or total saponins of panax japonicas in preparation of antithrombotic agents
10/31/2012CN102125539B Liver protection and bile secretion promotion preparation for fish and preparation method thereof
10/31/2012CN102119991B Composition with effects on blackening and increasing hair
10/31/2012CN102112446B Phenanthrenone compounds, compositions and methods
10/31/2012CN102106895B Composition with function of regulating blood fat
10/31/2012CN102106865B Application of bi-xanthone glycoside compound in oxidative damage resistance and apoptosis inhibition
10/31/2012CN102100807B Chinese medicine composition for regulating qi, widening chest and relieving pain as well as detection method thereof
10/31/2012CN102091027B Method for preparing antitumor small interfering RNA carrying magnetic nano probe
10/31/2012CN102070695B Preparation and application of ergosterin derivative
10/31/2012CN102068621B Chinese medicinal composition for treating infantile cold and fever and preparation method thereof
10/31/2012CN102030810B Gallic acid tea sapogenol ester as well as preparation method and application thereof
10/31/2012CN102018665B Strictosamide injection and preparation method thereof
10/31/2012CN102000092B New application of sulfadiazine sodium in preparing medicine for preventing or treating Bombyx mori septicemia
10/31/2012CN101985453B 4-aminopyridine derivative and preparation method and application thereof
10/31/2012CN101980711B Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors
10/31/2012CN101969951B Method of compound in preparing medicine for treating arthritis
10/31/2012CN101959514B Prophylactic or therapeutic agent for ocular disease accompanied by optic nerve disorder
10/31/2012CN101955462B Fenticonazole nitrate, preparation of levorotatory form and dextrorotatory form and application of levorotatory form in preparing antifungal medicaments
10/31/2012CN101940793B Hydroxypropyl-beta-cyclodextrin clathrate compound of cantharidin and cantharis extractive and preparation method thereof
10/31/2012CN101896174B Trans-clomiphene for metabolic syndrome
10/31/2012CN101891618B 2-[(2,3,4-trialkoxy-6-acyl) phenyl] acetic ester as well as preparation method and application thereof
10/31/2012CN101890049B Pediatric paracetamol oral solution formula and preparation method thereof
10/31/2012CN101879250B Arthralgia relief gel paste and preparation method
10/31/2012CN101861327B An amorphous form of an anti-inflammatory compound
10/31/2012CN101805763B Inonotus obliquus extracellular and intracellular mixing crude polysaccharide with function of strengthening immunity
10/31/2012CN101785854B Lutein multivitamin nutrition health care medicine composition and preparation method and applications thereof
10/31/2012CN101778826B Azepine derivatives as gamma-secretase inhibitors
10/31/2012CN101723896B Tyrosine derivative histone deacetylases inhibitor and application thereof
10/31/2012CN101711236B N-oxide and/or di-N-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
10/31/2012CN101687884B Macrolactone derivatives
10/31/2012CN101679317B Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor binding activity
10/31/2012CN101678005B Combination of a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist
10/31/2012CN101675032B Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands
10/31/2012CN101641095B Combination medicaments for treating bacterial infections
10/31/2012CN101611033B Indole derivatives as S1P1 receptor agonists
10/31/2012CN101594857B Crystalline forms of aliskiren hemifumarate
10/31/2012CN101575330B Novel voriconazole broad-spectrum antifungal medicine compound, broad-spectrum antifungal medicine composition and application thereof
10/31/2012CN101575320B Water-soluble triazole antifungal compound
10/31/2012CN101559097B Oxidation-resistant and anti-ageing health care product
10/31/2012CN101547902B pyridine derivatives for treatment of metabolic disorders related with insulin resistance and hyperglycemia
10/31/2012CN101535326B Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing same, drugs containing said compounds and use thereof
10/31/2012CN101511857B 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20- spirox-4-en-3-one) and pharmaceutical preparations containing the same
10/31/2012CN101511842B Dihydrofuro pyrimidines as AKT protein kinase inhibitors
10/31/2012CN101500557B Nitrofuran compounds for the treatment of cancer and angiogenesis
10/31/2012CN101481397B Novel kanamycin A derivative, and preparation and use thereof
10/31/2012CN101466379B Stable laquinimod preparations
10/31/2012CN101454297B Aryl-4-ethynyl-isoxazole derivatives
10/31/2012CN101426775B Oxadiazolidinedione compound
10/31/2012CN101411747B Salvia root polyphenol acid orally disintegrating tablets and preparation method thereof
10/31/2012CN101395171B Steroidal compounds as steroid sulphatase inhibitors
10/31/2012CN101395138B Sigma receptor inhibitors
10/31/2012CN101356173B Novel pyridopyrazines and their use as modulators of kinases
10/31/2012CN101318022B Metal-polysaccharide conjugates and synthesis method
10/31/2012CN101312960B F,G,H,I and K crystal forms of imatinib mesylate
10/31/2012CN101287712B Heterocyclic compounds
10/31/2012CN101278936B Clear eye lotion containing latanoprost as effective ingredient
10/31/2012CN101257890B Argatroban formulation comprising an acid as solubilizer
10/31/2012CN101244076B Pharmaceutical combination of azithromycin for eyes
10/31/2012CN101242816B Hcv inhibitors
10/31/2012CN101155579B Method for treating gefitinib resistant cancer
10/31/2012CN101142198B Isoxazole combretastatin derivatives for the treatment of disorders
10/31/2012CN101137395B Pharmaceutical composition containing hardly water soluble medicament
10/31/2012CN101049290B Application of agomelatine in preparing medicine for treating generalized anxiety disorder
10/31/2012CN101023947B Methods and compositions for bactericide, bacteriostatic and anti-inflammation
10/30/2012US8299285 Compounds for imaging and therapy
10/30/2012US8299267 (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating
10/30/2012US8299265 Amine derivatives having NPY Y5 receptor antagonistic activity and the uses thereof
10/30/2012US8299262 Pyridylmethyl-sulfonamide compounds
10/30/2012US8299258 Method of making piperidine derivatives
10/30/2012US8299257 Compounds which have activity at M1receptor and their uses in medicine
10/30/2012US8299253 Tris-quarternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
10/30/2012US8299252 Pyrazolopyridine and pyrrolopyridine multikinase inhibitors
10/30/2012US8299246 N-cyclopropyl-3-fluoro-5-[3-[[1-[2-[2- [(2-hydroxethyl)amino] ethoxy]phenyl] cyclopropyl] amino]-2-oxo-1 (2H)-pyrazinyl]-4-methyl-benzamide, or pharmaceutically acceptable salts thereof and their uses
10/30/2012US8299244 Melamine compound and method for manufacturing the same
10/30/2012US8299243 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
10/30/2012US8299234 siRNA hat inhibits WT1 gene expression and uses thereof
10/30/2012US8299213 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses
10/30/2012US8299178 Stable micelles formed with diblock copolymers of critical micelle concentration copolymer and temperature-sensitive copolymer
10/30/2012US8299147 Chemical resistant ionomers and protective coverings
10/30/2012US8299127 Method and composition for evenly applying water soluble actives
10/30/2012US8299126 Treatment of canine hemangiosarcoma with a histone deacetylase inhibitor
10/30/2012US8299125 Water-soluble triterpenephenol compounds having antitumor activity and the preparation thereof
10/30/2012US8299124 Aqueous intraocular penetration-promoting eye drop
10/30/2012US8299123 CCR10 antagonists
10/30/2012US8299122 Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition
10/30/2012US8299121 Softgel of NLKJ for treating prostate diseases
10/30/2012US8299120 Therapy for multiple sclerosis
10/30/2012US8299119 Biologically active compounds
10/30/2012US8299118 Enhanced bimatoprost ophthalmic solution
10/30/2012US8299117 GPR120 receptor agonists and uses thereof
10/30/2012US8299116 CCI-779 concentrate formulations
10/30/2012US8299115 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
10/30/2012US8299114 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
10/30/2012US8299113 Bicyclic tetrahydropyrrole compounds
10/30/2012US8299112 Estrogen receptor modulators and uses thereof
10/30/2012US8299111 Compounds which modulate the CB2 receptor
10/30/2012US8299110 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors
10/30/2012US8299108 Substituted benzazoles and methods of their use as inhibitors of raf kinase
10/30/2012US8299107 Triazole compounds that modulate HSP90 activity
10/30/2012US8299106 Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases
1 ... 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 ... 7860